Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages 18710-18715

  Wenzel, Daniela ^a   Matthey, Michaela ^a   Bindila, Laura ^b   Lerner, Raissa ^b   Lutz, Beat ^b   Zimmer, Andreas ^a   Fleischmann, Bernd K ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cannabinoid; Pulmonary vascular tone

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FATTY ACID AMIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY TONE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; FEMALE; HYPOXIC LUNG VASOCONSTRICTION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

CANNABINOID; PULMONARY VASCULAR TONE;

AMIDOHYDROLASES; ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; ARACHIDONIC ACIDS; BENZAMIDES; BLOTTING, WESTERN; CARBAMATES; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; ENDOCANNABINOIDS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; POLYUNSATURATED ALKAMIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 84887436170     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308130110     Document Type: Article

References (31)

1. Járai Z, et al. (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96(24): 14136-14141.
2. Bátkai S, et al. (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110(14):1996-2002.
3. Herradón E, Martín MI, López-Miranda V (2007) Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol 152(5): 699-708.
4. Gauthier KM, et al. (2005) Endothelium-derived 2-arachidonylglycerol: An intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol 288(3):H1344-H1351. (Pubitemid 40270043)
5. Neumann P, Hedenstierna G (2001) Ventilation-perfusion distributions in different porcine lung injury models. Acta Anaesthesiol Scand 45(1):78-86. (Pubitemid 32014979)
6. Hedenstierna G, Söderman C, Eriksson LS, Wahren J (1991) Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J 4(6):711-717.
7. Maggiorini M, et al. (2001) High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103(16):2078-2083. (Pubitemid 32373011)
8. Ghofrani HA, et al. (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 360(9337):895-900. (Pubitemid 35283832)
9. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB (1977) Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest 59(2):203-216. (Pubitemid 8055678)
10. Murray TR, Chen L, Marshall BE, Macarak EJ (1990) Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. Am J Respir Cell Mol Biol 3(5):457-465.
11. Wahn H, Wolf J, Kram F, Frantz S, Wagner JA (2005) The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclo-oxygenase-2 products in isolated rabbit lungs. Am J Physiol Heart Circ Physiol 289(6): H2491-H2496. (Pubitemid 41698562)
12. Kozłowska H, et al. (2007) Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. J Hypertens 25(11):2240-2248.
13. Monteleone P, et al. (2005) Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30(6):1216-1221. (Pubitemid 40720981)
14. Joosten MM, Balvers MG, Verhoeckx KC, Hendriks HF, Witkamp RF (2010) Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women. Nutr Metab (Lond) 7:49.
15. Voelkel NF, Morganroth M, Feddersen OC (1985) Potential role of arachidonic acid metabolites in hypoxic pulmonary vasoconstriction. Chest 88(4, Suppl):245S-248S. (Pubitemid 16255481)
16. Kiss L, et al. (2008) Direct and simultaneous profiling of epoxyeicosatrienoic acid enantiomers by capillary tandem column chiral-phase liquid chromatography with dual online photodiode array and tandem mass spectrometric detection. Anal Bioanal Chem 392(4):717-726.
17. Dorrington KL, et al. (1997) Time course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. Am J Physiol 273(3 Pt 2):H1126-H1134.
18. Okamoto Y, et al. (2005) Mammalian cells stably overexpressing N-acylphosphatidy-lethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines. Biochem J 389(Pt 1):241-247. (Pubitemid 40978028)
19. Pacher P, et al. (2005) Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol 289(2):H533-H541. (Pubitemid 41129366)
20. Mach F, Steffens S (2008) The role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol 20(Suppl 1):53-57. (Pubitemid 351552677)
21. Zygmunt PM, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400(6743):452-457. (Pubitemid 29361798)
22. Grainger J, Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: The role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134(5):1003-1012. (Pubitemid 33052159)
23. Raj JU, Chen P (1987) Role of eicosanoids in hypoxic vasoconstriction in isolated lamb lungs. Am J Physiol 253(3 Pt 2):H626-H633.
24. Pokreisz P, et al. (2006) Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 47(4):762-770. (Pubitemid 43740249)
25. Stenmark KR, et al. (1983) Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 309(2):77-80. (Pubitemid 13063590)
26. Wang L, et al. (2012) Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest 122(11):4218-4230.
27. Simon GM, Cravatt BF (2008) Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem 283(14):9341-9349.
28. Liu J, et al. (2006) A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103(36):13345-13350. (Pubitemid 44380110)
29. Waypa GB, et al. (2013) Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med 187(4):424-432.
30. Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF (2005) Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41(5):1085-1095. (Pubitemid 40593916)
31. Clapper JR, et al. (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13(10):1265-1270.